Business Trends– category –
-
Medtronic Introduces Instinct Sensor, Expands MiniMed 780G System to Type 2 Diabetes with Dual FDA Clearances
Simply Wall St USA Overview Medtronic has expanded its diabetes sensor portfolio with the launch of the Instinct sensor, complementing its Simplera Sync™ and Guardian™ 4 sensors. The company also secured two key U.S. FDA regulatory miles... -
Diabeloop and ViCentra Launch Smartphone-Controlled DBLG2 System Integrated with Kaleido Patch Pump and Dexcom G7 CGM for Prescription in Germany
Press Release Hub Germany Overview Diabeloop and ViCentra have launched their DBLG2 Automated Insulin Delivery (AID) system for prescription in Germany, integrating ViCentra's Kaleido insulin patch pump with the Dexcom G7 Continuous Gluc... -
Creative Biolabs Integrates Microfluidics and Electrochemical Biosensors to Accelerate Next-Generation POCT Diagnostics
24-7 Press Release USA Overview Creative Biolabs has announced a new platform integrating microfluidics and electrochemical biosensors, aiming to accelerate next-generation Point-of-Care Testing (POCT) diagnostics. This combination achie... -
UT Southwestern Develops Metabolite-Specific Biosensor for Early Diagnosis of Childhood Brain Disorders
UT Southwestern Medical Center USA Overview Researchers at UT Southwestern Medical Center have developed a metabolite-specific biosensor for diagnosing certain childhood brain disorders. This sensor enables highly sensitive detection of ... -
Shanghai Chip Startups Challenge Nvidia’s GPU Dominance with Sub-1nm 3D Stacking and Nanoimprint Tech
Bloomberg China Overview Shanghai chip startups are leveraging advanced 3D stacking and nanoimprint technologies to challenge Nvidia's GPU market dominance. Shanghai Atomic Technology launched a pilot line in January 2026 targeting sub-1... -
Novel Stem Cell Approach Aims for Functional Cure in Diabetes, Pioneering Immunosuppression-Free Islet Cell Transplantation
News-Medical International Overview A new stem cell approach is targeting a functional cure for diabetes, specifically focusing on the potential for islet cell transplantation without immunosuppression, as reported on July 11, 2026. This... -
Wugen Rebrands as Allotera, Closes $35 Million Financing Round to Accelerate Off-the-Shelf Cell Therapy Development for Cancer and Autoimmune Diseases
Cellgenetherapyreview.com USA Overview On July 10, 2026, Wugen announced its rebranding to Allotera and the successful completion of a $35 million financing round. This rebranding and capital infusion represent a significant strategic st... -
Lyora Launches with Seed Funding to Propel Ophthalmic Gene Therapy Assets, Targeting IND Submission Within 18 Months
Cellgenetherapyreview.com USA Overview Lyora announced on July 14, 2026, the successful completion of its seed funding round and the official launch of operations, aimed at advancing its ophthalmic gene therapy assets. The company plans ... -
Ocugen Forges Strategic Alliance to Bring Broad-Spectrum OCU400 Gene Therapy to MENA Region
Cellgenetherapyreview.com USA, Middle East and North Africa Overview Ocugen, Inc. announced on July 15, 2026, an exclusive licensing agreement with Roots Pharma and Al-Dhow International to commercialize OCU400, its innovative modifier g... -
Tempest Therapeutics to Advance In Vivo CAR T-Cell Therapy TPST-4003 into Clinical Trials by Year-End for Autoimmune Diseases like Myasthenia Gravis and Multiple Sclerosis
Biotech News Portal USA Overview Tempest Therapeutics announced on July 16, 2026, that its lead in vivo CAR T-cell product candidate, TPST-4003, is slated to enter clinical trials by year-end. This candidate will be evaluated in investig...
